PARP1 and neoplasm: This combinatorial regimen induces G2-phase cell cycle arrest, apoptosis, and extensive DNA damage; however, ATR inhibition alone significantly impairs xenograft tumour growth, with no additional therapeutic advantage conferred by PARP inhibition.